| MESO Snapshot | |
|---|---|
| Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia. | |
| VALUATION DATA | |
| Market Capitalization | $692,890,000 | Price to Sales | 1.00 |
| Earnings per Share | $-0.8700 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $6.1500 |
| 52 Week High | $76.44 |
| 52 Week Low | $1.071 |
| 50-Day Moving Average | $82.44 |
| 200-Day Moving Average | $-12.64 |
| All data are from Alpha Vantage as of today. For more infomation on MESO see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search